Results 21 to 30 of about 6,452 (220)
BMC Gastroenterology, 2022 Background Transarterial radioembolization (TARE) with yttrium-90 microspheres is a clinically effective therapy for hepatocellular carcinoma (HCC) treatment.
J. C. Alonso +9 more
doaj +1 more source
The Arab Journal of Interventional Radiology, 2023 Transarterial radioembolization (TARE) is a widely used treatment method for primary liver cancers and metastasis. Although TARE is relatively safe, it may cause liver abscess, failure, nontarget embolization, and vascular complications.
Muhammet Arslan +3 more
doaj +1 more source
Diagnostic and Interventional Radiology, 2023 PURPOSETo analyze changes in angiogenesis factors after transarterial radioembolization (TARE) with Yttrium- 90-loaded resin microspheres in hepatocellular carcinoma (HCC) patients.METHODSInterleukin-6, interleukin-8, hepatocyte growth factor, platelet ...
Hüseyin Tuğsan Ballı +3 more
doaj +1 more source
Naše More (Dubrovnik), 2018 This paper focuses on the methods of obtaining Verified Gross Mass of packed containers or other Intermodal Loading Units in Slovakia taking into consideration requirements of section 4 to 6, Regulation 2, Part A, chapter VI SOLAS and article 10f of the ...
Juraj Jagelčák +2 more
doaj +1 more source
PLoS ONE, 2020 Conventional transarterial chemoembolization (cTACE), drug-eluting beads (DEB-TACE) and transarterial radioembolization (TARE) are alternative strategies for unresectable hepatocellular carcinoma (HCC).
Biao Yang +5 more
doaj +1 more source
Superselective transarterial radioembolization for the treatment of hepatocellular carcinoma
International Journal of Gastrointestinal Intervention, 2021 Superselective transarterial radioembolization (TARE) refers the delivery of Y90 at the tumor-feeding segmental or subsegmental arteries. The purpose of TARE would be delivering high dose in the tumor while saving as much normal parenchyma as possible ...
Gyoung Min Kim
doaj +1 more source
Current Updates in Diagnosis and Management of Hepatocellular Carcinoma with Special Reference to Interventional Radiology [PDF]
National Radiology Journal of PakistanHepatocellular Carcinoma (HCC) accounts for the sixth most common cancer, implying considerable disease burden. Liver Ultrasound (US) and the use of certain serum biomarkers, like Alpha-Feto Protein (AFP) and Protein induced by vitamin K absence or ...
Muhammad Azeemuddin +4 more
doaj +1 more source
DEVELOPMENT OF CAN PASTEURIZATION WITH REFERENCE TO CONTINUOUS OPEN TYPE APPARATUS
Вестник Дагестанского государственного технического университета: Технические науки, 2016 In the paper are considered the problems connected with the development of scientifically valid can pasteurization regimes in the self-exhaustion tare in continuous open type apparatus operating under atmosphere pressure.
K. R. Gammatsaev, L. R. Ibragimova
doaj +1 more source
Therapeutic Advances in Gastroenterology, 2023 Background: Transarterial radioembolization (TARE) is increasingly used in patients with hepatocellular carcinoma (HCC). This treatment can induce or impair portal hypertension, leading to hepatic decompensation.
Laura Carrión +12 more
doaj +1 more source
Hepatology Communications, 2022 Transarterial radioembolization (TARE) is a well‐established therapy for intermediate and advanced tumor stages of hepatocellular carcinoma (HCC). Treatment‐associated toxicities are rare.
Marlene Reincke +8 more
doaj +1 more source